Susquehanna International Group, LLP Cue Biopharma, Inc. Transaction History

Susquehanna International Group, LLP

  • $823 Billion
  • Q3 2025

A detailed history of Susquehanna International Group, LLP transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 166,456 shares of CUE stock, worth $104,867. This represents 0.0% of its overall portfolio holdings.

Number of Shares
166,456
Previous 154,243 7.92%
Holding current value
$104,867
Previous $104,000 11.54%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$0.67 - $0.9 $8,182 - $10,991
12,213 Added 7.92%
166,456 $116,000
Q2 2025

Aug 14, 2025
BUY
$0.58 - $0.86 $89,460 - $132,648
154,243 New
154,243 $104,000
Q4 2024

Feb 14, 2025
BUY
$0.71 - $1.88 $9,413 - $24,925
13,258 New
13,258 $13,000
Q2 2024

Aug 15, 2024
BUY
$1.24 - $2.18 $106,723 - $187,626
86,067 Added 255.73%
119,722 $148,000
Q1 2024

May 07, 2024
BUY
$1.77 - $3.09 $34,984 - $61,073
19,765 Added 142.3%
33,655 $63,000
Q4 2023

Feb 14, 2024
SELL
$1.72 - $3.1 $101,225 - $182,441
-58,852 Reduced 80.91%
13,890 $36,000
Q3 2023

Nov 14, 2023
BUY
$2.23 - $4.69 $15,781 - $33,191
7,077 Added 10.78%
72,742 $167,000
Q2 2023

Aug 11, 2023
SELL
$3.11 - $4.91 $207,965 - $328,331
-66,870 Reduced 50.45%
65,665 $239,000
Q1 2023

May 16, 2023
BUY
$2.41 - $3.74 $319,409 - $495,680
132,535 New
132,535 $473,000
Q3 2022

Nov 14, 2022
SELL
$2.23 - $3.37 $304,256 - $459,796
-136,438 Reduced 82.68%
28,573 $64,000
Q2 2022

Aug 15, 2022
BUY
$2.49 - $5.92 $234,784 - $558,202
94,291 Added 133.33%
165,011 $411,000
Q1 2022

May 16, 2022
BUY
$4.41 - $12.28 $102,382 - $285,092
23,216 Added 48.87%
70,720 $345,000
Q4 2021

Feb 14, 2022
BUY
$10.86 - $17.85 $203,049 - $333,741
18,697 Added 64.9%
47,504 $537,000
Q3 2021

Nov 15, 2021
SELL
$10.06 - $15.3 $164,048 - $249,497
-16,307 Reduced 36.15%
28,807 $420,000
Q2 2021

Aug 11, 2021
SELL
$10.9 - $14.53 $123,638 - $164,813
-11,343 Reduced 20.09%
45,114 $526,000
Q1 2021

May 17, 2021
BUY
$11.2 - $16.09 $372,052 - $534,493
33,219 Added 142.95%
56,457 $689,000
Q4 2020

Feb 16, 2021
SELL
$11.12 - $16.4 $79,641 - $117,456
-7,162 Reduced 23.56%
23,238 $291,000
Q3 2020

Nov 16, 2020
BUY
$15.05 - $23.54 $118,202 - $184,883
7,854 Added 34.84%
30,400 $458,000
Q2 2020

Aug 14, 2020
BUY
$12.7 - $30.73 $286,334 - $692,838
22,546 New
22,546 $553,000

Others Institutions Holding CUE

# of Institutions
53
Shares Held
18.4M
Call Options Held
0
Put Options Held
0
View Full List

About Cue Biopharma, Inc.

CUE Quotes by TradingView
  • Ticker CUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,381,700
  • Market Cap $22.3M
  • Description
  • Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...
More about CUE
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email